Antiprogestin Pharmacodynamics, Pharmacokinetics, and Metabolism: Implications for Their Long-Term Use Graham R. JangLeslie Z. Benet OriginalPaper 01 December 1997 Pages: 647 - 672
Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A1-Receptor Agonists Erno A. van SchaickHenrik J. M. M. de GreefMeindert Danhof OriginalPaper 01 December 1997 Pages: 673 - 694
Implementation and Evaluation of a Stochastic Control Strategy for Individualizing Teicoplanin Dosage Regimen Michel TodPatrice AletOlivier Petitjean OriginalPaper 01 December 1997 Pages: 695 - 712
A Pharmacokinetic–Pharmacodynamic Model of Chemotherapy of Human Immunodeficiency Virus Infection that Relates Development of Drug Resistance to Treatment Intensity Robert C. Jackson OriginalPaper 01 December 1997 Pages: 713 - 730
Membrane Transporters in Drug Disposition Kathleen M. Giacomini OriginalPaper 01 December 1997 Pages: 731 - 741
Bioequivalence: Issues and Options Kamal K. MidhaMaureen J. RawsonJohn W. Hubbard OriginalPaper 01 December 1997 Pages: 743 - 752
A Note on Sample Size Determination for Bioequivalence Studies with Higher-Order Crossover Designs Keh-Wei ChenShein-Chung ChowGang Li OriginalPaper 01 December 1997 Pages: 753 - 765